
Most women know menopause can bring hot flashes, disrupted sleep, vaginal dryness, changes in libido, and shifts in body composition.
But there is another change that deserves far more attention:
A woman’s cardiovascular risk increases as she moves through menopause and into her postmenopausal years.
Cardiovascular disease remains the leading cause of death among women in the United States. Yet many women reach menopause having spent decades thinking much more about breast cancer than about heart disease.
Menopause is an important opportunity to change that conversation.
It isn’t simply the end of menstrual periods. It is a major biological transition that can affect cholesterol, blood vessels, blood pressure, insulin sensitivity, body composition, inflammation, and other factors involved in cardiovascular health.
Understanding those changes gives us an opportunity to identify risk earlier—and potentially do something about it.
Before menopause, women generally develop cardiovascular disease later in life than men.
That advantage begins to narrow as women age and transition through menopause.
Age itself is certainly part of the explanation. We cannot attribute every change occurring at menopause to estrogen loss.
But research suggests that the menopause transition itself is associated with unfavorable changes in several cardiovascular risk factors.
One of the major biological changes during this period is the decline in ovarian estrogen production.
Estrogen has effects throughout the cardiovascular system. It influences vascular function, lipid metabolism, glucose metabolism, inflammation, and body-fat distribution.
As estrogen declines, the cardiovascular environment can change.
One of the most important changes occurring around menopause involves lipids.
LDL cholesterol often increases during the menopause transition.
Apolipoprotein B, or ApoB, may also increase.
ApoB represents the number of atherogenic lipoprotein particles capable of entering the arterial wall and participating in atherosclerosis.
That distinction is important.
Two women can have similar LDL cholesterol concentrations but different numbers of atherogenic particles.
For some women, looking beyond total cholesterol and LDL cholesterol can provide additional information about cardiovascular risk.
That doesn’t mean every woman needs advanced cardiovascular testing.
It means testing should be individualized according to her history and risk.
Many women tell me:
“I’m eating the same way and exercising the same way, but my body is changing.”
They’re not imagining it.
During and after menopause, women commonly experience changes in body composition, including a tendency toward greater abdominal and visceral fat accumulation.
Visceral fat is the metabolically active fat surrounding internal organs.
It isn’t simply a cosmetic issue.
Greater visceral adiposity is associated with insulin resistance, metabolic dysfunction, inflammation, and increased cardiovascular risk.
This is one reason the scale alone doesn’t tell us everything we need to know about a woman’s health.
Maintaining muscle, staying physically active, and paying attention to metabolic health become increasingly important during this stage of life.
Blood pressure also tends to rise as women get older.
By midlife and beyond, hypertension becomes increasingly common among women.
High blood pressure can quietly damage arteries, the heart, kidneys, brain, and other organs for years without producing obvious symptoms.
That makes knowing your blood pressure incredibly important.
You don’t want the first indication of hypertension to be a cardiovascular event.
The menopause transition can also coincide with changes in insulin sensitivity and glucose metabolism.
For some women, this contributes to increasing:
And metabolic health and cardiovascular health are intimately connected.
This is why I don’t believe menopause care should consist only of asking:
“Are you having hot flashes?”
We should be thinking about the whole woman.
Here’s something many women don’t realize.
Your cardiovascular history may have started decades before menopause.
Did you have:
Certain pregnancy complications are associated with greater cardiovascular risk later in life.
Yet many women never realize that something that happened during a pregnancy 20 or 30 years ago may still be relevant to their health today.
Your reproductive history is part of your cardiovascular history.
Some cardiovascular risk factors are inherited.
One particularly important example is lipoprotein(a), or Lp(a).
Lp(a) is largely genetically determined and is associated with increased risk of atherosclerotic cardiovascular disease and calcific aortic valve disease.
Lifestyle changes are incredibly important for overall cardiovascular health, but they generally have relatively little effect on Lp(a).
That makes knowing whether it is elevated potentially valuable.
Current cardiovascular guidelines increasingly support measuring Lp(a) at least once in adulthood.
Family history matters too.
If your mother, father, brother, or sister experienced premature cardiovascular disease, make sure your healthcare provider knows.
Inflammation is another piece of the cardiovascular puzzle.
Atherosclerosis isn’t simply cholesterol accumulating inside a pipe.
It is a complex biological process involving lipoproteins, the arterial wall, immune activity, and inflammation.
For selected women, markers such as high-sensitivity C-reactive protein—hs-CRP—may provide additional information when evaluating cardiovascular risk.
Again, this isn’t about ordering every available laboratory test.
It’s about asking:
Will this information help us make a better decision for this particular woman?
That’s precision testing.
Sometimes.
A routine lipid panel remains extremely useful and should not be dismissed.
But depending upon a woman’s age, family history, medical history, symptoms, and existing risk factors, additional evaluation may be appropriate.
That might include:
A coronary artery calcium—or CAC—scan is a low-dose CT examination that detects calcified plaque in the coronary arteries.
For appropriately selected adults whose cardiovascular risk or treatment decisions remain uncertain, CAC scoring can sometimes help refine the conversation.
Carotid ultrasound can also identify carotid plaque, although routine measurement of carotid intima-media thickness, or CIMT, is not universally recommended as a screening test. Its usefulness depends considerably on the clinical situation and how the study is performed and interpreted.
The important point isn’t that every woman needs imaging.
The important point is that we have tools available when additional information would meaningfully change management.
This is where the conversation requires nuance.
Menopausal hormone therapy can be highly effective for treating bothersome vasomotor symptoms and genitourinary symptoms of menopause and can help prevent bone loss in appropriately selected women.
For many healthy women who are younger than 60 or within approximately 10 years of menopause onset and who do not have contraindications, the overall benefit-risk profile of hormone therapy is generally favorable when treatment is individualized.
But hormone therapy should not be prescribed solely for the purpose of preventing cardiovascular disease.
Timing, formulation, route of administration, dose, medical history, and individual cardiovascular and thrombotic risk all matter.
This is exactly why menopause care should be personalized.
The question shouldn’t simply be:
“Are hormones good or bad?”
The better question is:
“What are the potential benefits and risks for this particular woman?”
I don’t look at menopause simply as something women need to “get through.”
I see it as an extraordinary opportunity to reassess health.
This is the time to ask:
What is my blood pressure?
What does my lipid profile look like?
Do I know my ApoB?
Have I ever had my Lp(a) measured?
How is my glucose metabolism?
Am I maintaining muscle?
Am I accumulating visceral fat?
What is my family history?
What happened during my pregnancies?
Am I sleeping well?
Am I exercising?
Do I smoke?
And is there additional testing that would meaningfully change what I do next?
That is a very different conversation from simply asking whether your hot flashes have improved.
Precision optimization isn’t about performing every test available or trying to make every laboratory result “perfect.”
It’s about gathering the information that matters and using it intelligently.
Sometimes routine testing provides everything we need.
Sometimes family history tells us we should look deeper.
Sometimes an advanced biomarker reveals inherited risk.
Sometimes imaging changes the entire conversation.
And sometimes additional testing confirms that we’re already doing exactly what we should be doing.
The goal isn’t more information simply for the sake of having information.
The goal is information that allows a woman and her healthcare provider to make better decisions together.
Menopause isn’t a cardiovascular disease.
But the menopause transition occurs during a period when a woman’s cardiovascular risk profile can change significantly.
That makes midlife one of the most important opportunities we have to talk about prevention.
Know your blood pressure.
Know your metabolic health.
Know your cholesterol.
Know your family history.
Know your pregnancy history.
Ask whether additional testing is appropriate for you.
Build and preserve muscle.
Move your body.
Don’t smoke.
Prioritize sleep.
Eat in a way that supports metabolic and cardiovascular health.
And have an individualized conversation about menopause treatment when symptoms are affecting your quality of life.
Most importantly, don’t wait until you have cardiovascular disease to become interested in cardiovascular prevention.
Menopause isn’t the end of the story.
For many women, it’s the beginning of several more decades of life.
Let’s make those decades as strong, healthy, informed, and independent as possible.
Curiosity is the beginning of optimization.
This article is intended for educational purposes only and does not constitute individualized medical advice, diagnosis, or treatment. Talk with a qualified healthcare professional about your individual health history, cardiovascular risk, and treatment options.
Join our list
Navigate
Contact
Home
About
Service
Blog
FAQ
Contact
Email: Myessentialwoman@gmail.com
Fax: 352-995-0004
1405 SW 6th Ave, Ocala, FL 34471
Licenses
ANCC # 104415489
APRN9191380
Phone: 352-425-1704
Receive updates on special promotions, exclusive events and announcements.
Thank You!